George Clinical and EPS Collaborate on Important HR+/HER2- Breast Cancer Study in Asia Pacific
SYDNEY, June 27, 2023 (GLOBE NEWSWIRE) — George Clinical and EPS Corporation (EPS), a global CRO based in Japan are collaborating on a rare Japanese academia-led global study seeking to